Skip to main content
Premium Trial:

Request an Annual Quote

Decode Genetics Seeks Hearing Before Nasdaq Listing Panel

NEW YORK (GenomeWeb News) – Decode Genetics said today that it has requested a hearing before a Nasdaq Listing Qualifications Panel to present its plans for regaining compliance with a Nasdaq market rule regarding the market value of its stock.
 
The Reykjavik, Iceland-based firm received a letter from Nasdaq in early October stating that for 10 consecutive trading days the market value of its common stock was below $50 million, the minimum level required for continued listing on the Nasdaq Global Market. The firm’s shares also did not comply with an alternative test set forth by a Nasdaq rule, which requires total assets and total revenue of $50 million each for the most recently completed fiscal year or two of the last three most recently completed fiscal years.  
 
According to that letter, Decode’s stock is subject to delisting at the opening of business on Nov. 11, if it doesn’t regain compliance. Decode said that its shares would continue to be listed on the exchange pending conclusion of its hearing, which is expected to take place within 45 days. The firm also noted that the Nasdaq panel has the discretion to grant a listing extension for up to 180 days from the date of staff notification for the company to regain compliance with regulations.
 
Decode said that it may apply to transfer its securities to the Nasdaq Capital Market if it satisfies the continued inclusion requirements for that market, which include a minimum aggregate market value of listed securities of $35 million. As of yesterday’s stock market close, Decode’s market value of listed securities was $26.6 million, based on a closing price of $.43 per share.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.